Lpl Financial LLC Intellia Therapeutics, Inc. Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 56,595 shares of NTLA stock, worth $860,809. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,595
Previous 57,326 1.28%
Holding current value
$860,809
Previous $1.28 Million 9.28%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$19.72 - $27.36 $14,415 - $20,000
-731 Reduced 1.28%
56,595 $1.16 Million
Q2 2024

Aug 07, 2024
BUY
$20.02 - $27.22 $114,814 - $156,106
5,735 Added 11.12%
57,326 $1.28 Million
Q1 2024

May 10, 2024
BUY
$23.82 - $32.8 $120,410 - $165,804
5,055 Added 10.86%
51,591 $1.42 Million
Q4 2023

Feb 14, 2024
BUY
$23.16 - $32.34 $40,252 - $56,206
1,738 Added 3.88%
46,536 $1.42 Million
Q3 2023

Nov 13, 2023
BUY
$31.62 - $45.78 $6,924 - $10,025
219 Added 0.49%
44,798 $1.42 Million
Q2 2023

Jul 31, 2023
BUY
$34.58 - $46.03 $207,410 - $276,087
5,998 Added 15.55%
44,579 $1.82 Million
Q1 2023

May 10, 2023
BUY
$33.3 - $44.82 $86,246 - $116,083
2,590 Added 7.2%
38,581 $1.44 Million
Q4 2022

Feb 07, 2023
SELL
$33.21 - $62.69 $125,400 - $236,717
-3,776 Reduced 9.5%
35,991 $1.26 Million
Q3 2022

Nov 14, 2022
SELL
$53.92 - $71.7 $110,859 - $147,415
-2,056 Reduced 4.92%
39,767 $2.23 Million
Q2 2022

Aug 12, 2022
BUY
$38.49 - $76.21 $35,102 - $69,503
912 Added 2.23%
41,823 $2.17 Million
Q1 2022

May 16, 2022
SELL
$58.27 - $118.99 $217,463 - $444,070
-3,732 Reduced 8.36%
40,911 $2.97 Million
Q4 2021

Feb 14, 2022
BUY
$100.76 - $138.36 $89,777 - $123,278
891 Added 2.04%
44,643 $5.28 Million
Q3 2021

Nov 15, 2021
BUY
$132.37 - $176.78 $240,516 - $321,209
1,817 Added 4.33%
43,752 $5.87 Million
Q2 2021

Aug 13, 2021
SELL
$60.88 - $161.91 $719,966 - $1.91 Million
-11,826 Reduced 22.0%
41,935 $6.79 Million
Q1 2021

May 14, 2021
BUY
$46.59 - $83.68 $487,051 - $874,790
10,454 Added 24.14%
53,761 $4.32 Million
Q4 2020

Feb 12, 2021
BUY
$18.83 - $63.53 $234,621 - $791,583
12,460 Added 40.39%
43,307 $2.36 Million
Q3 2020

Nov 09, 2020
BUY
$17.47 - $24.93 $76,972 - $109,841
4,406 Added 16.66%
30,847 $613,000
Q2 2020

Aug 13, 2020
BUY
$11.14 - $22.87 $160,516 - $329,533
14,409 Added 119.76%
26,441 $556,000
Q1 2020

May 14, 2020
BUY
$9.44 - $15.58 $113,582 - $187,458
12,032 New
12,032 $147,000

Others Institutions Holding NTLA

# of Institutions
315
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.16B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email